Intrauterine enzyme replacement therapies for lysosomal storage disorders: Current developments and promising future prospects
Prenatal Diagnosis · 2023-12 · 43 (13) · 1638-1649
DOI: 10.1002/pd.6460 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Prenatal Diagnosis, online erschienen am 13.11.2023. Verfasst von Akos Herzeg und 13 weiteren Autor:innen. Beteiligte Einrichtung: Center for Maternal-Fetal Precision Medicine, University of California, San Francisco, California, USA. Hauptthemen laut MEDLINE: Enzyme Replacement Therapy, Lysosomal Storage Diseases. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NICHD NIH HHS, NIH Clinical Center.
Abstract (Originalsprache)
Lysosomal storage disorders (LSDs) are a group of monogenic condition, with many characterized by an enzyme deficiency leading to the accumulation of an undegraded substrate within the lysosomes. For those LSDs, postnatal enzyme replacement therapy (ERT) represents the standard of care, but this treatment has limitations when administered only postnatally because, at that point, prenatal disease sequelae may be irreversible. Furthermore, most forms of ERT, specifically those administered systemically, are currently unable to access certain tissues, such as the central nervous system (CNS), and furthermore, may initiate an immune response. In utero enzyme replacement therapy (IUERT) is a novel approach to address these challenges evaluated in a first‐in‐human clinical trial for IUERT in LSDs (NCT04532047). IUERT has numerous advantages: in‐utero intervention may prevent early pathology; the CNS can be accessed before the blood‐brain barrier forms; and the unique fetal immune system enables exposure to new proteins with the potential to prevent an immune response and may induce sustained tolerance. However, there are challenges and limitations for any fetal procedure that involves two patients. This article reviews the current state of IUERT for LSDs, including its advantages, limitations, and potential future directions for definitive therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Center for Maternal-Fetal Precision Medicine, University of California, San Francisco, California, USA.
- Department of Surgery, University of California, San Francisco, California, USA.
- Department of Obstetrics and Gynecology and Reproductive Sciences, University of California, San Francisco, California, USA.
- Department of Pediatrics, Division of Medical Genetics, Duke University, Durham, North Carolina, USA.
- Department of Chemistry, University of Washington, Seattle, Washington, USA.
- Department of Pediatrics, Children's Hospital of Eastern Ontario and University of Ottawa, Ottawa, Ontario, Canada.
ORCID-Profile: Akos Herzeg
Förderung
- NICHD NIH HHS
- NIH Clinical Center
Zitieren
APA
Herzeg, A., Borges, B., Lianoglou, B. R., Gonzalez-Velez, J., Canepa, E., Munar, D., Young, S. P., Bali, D., Gelb, M. H., Chakraborty, P., Kishnani, P. S., Harmatz, P., Cohen, J. L., & MacKenzie, T. C. (2023). Intrauterine enzyme replacement therapies for lysosomal storage disorders: Current developments and promising future prospects. Prenatal Diagnosis, 43(13), 1638-1649. https://doi.org/10.1002/pd.6460
Vancouver
Herzeg A, Borges B, Lianoglou BR, Gonzalez-Velez J, Canepa E, Munar D, et al. Intrauterine enzyme replacement therapies for lysosomal storage disorders: Current developments and promising future prospects. Prenatal Diagnosis. 2023;43(13):1638-1649. doi:10.1002/pd.6460
BibTeX
@article{Herzeg2023,
author = {Herzeg, Akos and Borges, Beltran and Lianoglou, Billie R and Gonzalez-Velez, Juan and Canepa, Emma and Munar, Dane and Young, Sarah P and Bali, Deeksha and Gelb, Michel H and Chakraborty, Pranesh and Kishnani, Priya S and Harmatz, Paul and Cohen, Jennifer L and MacKenzie, Tippi C},
title = {Intrauterine enzyme replacement therapies for lysosomal storage disorders: Current developments and promising future prospects},
journal = {Prenatal Diagnosis},
year = {2023},
volume = {43},
number = {13},
pages = {1638--1649},
doi = {10.1002/pd.6460}
}
EUVIMED